s6y
Company name or ticker
Search
Drapkin Kimberlee C
4
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Wednesday, June 7, 2023
Period
Jun 6, 2023
Accession number
0001576885-23-000032
Documents
FORM 4
4
EX-24.1
EX-24.1
On sec.gov
Filing index
All files
Complete submission text
SGML header